In the last trading session, 14.75 million shares of the iSpecimen Inc (NASDAQ:ISPC) were traded, and its beta was 1.68. Most recently the company’s share price was $2.37, and it changed around -$0.48 or -16.84% from the last close, which brings the market valuation of the company to $2.28M. ISPC currently trades at a discount to its 52-week high of $11.80, offering almost -397.89% off that amount. The share price’s 52-week low was $2.50, which indicates that the current value has fallen by an impressive -5.49% since then. We note from iSpecimen Inc’s average daily trading volume that its 10-day average is 1.92 million shares, with the 3-month average coming to 547.52K.
iSpecimen Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ISPC as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. iSpecimen Inc is expected to report earnings per share of 0 for the current quarter.
iSpecimen Inc (NASDAQ:ISPC) trade information
Instantly ISPC has showed a red trend with a performance of -16.84% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.38 on recent trading dayincreased the stock’s daily price by 29.88%. The company’s shares are currently down -10.73% year-to-date, but still down -11.57% over the last five days. On the other hand, iSpecimen Inc (NASDAQ:ISPC) is -27.52% down in the 30-day period. We can see from the shorts that 71667.0 shares have been sold at a short interest cover period of 0.18 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.55%.
ISPC Dividends
iSpecimen Inc’s next quarterly earnings report is expected to be released in February.
iSpecimen Inc (NASDAQ:ISPC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 14.50% of iSpecimen Inc shares, and 2.85% of them are in the hands of institutional investors. The stock currently has a share float of 3.33%. iSpecimen Inc stock is held by 5.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 0.6191% of the shares, which is about 56538.0 shares worth $17470.0.
HRT FINANCIAL LP, with 0.503% or 45935.0 shares worth $14000.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Nov 30, 2024 . The former held 2.6 shares worth $6152.0, making up 0.27% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 1.8 shares worth around $4265.0, which represents about 0.19% of the total shares outstanding.
